The Biosimilars Act: The United States’ Entry into Regulating Biosimilars and its Implications

The John Marshall Review of Intellectual Property Law. March 2013

Contact Banner Witcoff Share on LinkedIn View this page as a pdf Share on Twitter Email this page Print this page